Literature DB >> 22882420

Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases.

Susanne Schiffner, Suzie Chen, Jürgen C Becker, Anja-Katrin Bosserhoff.   

Abstract

Murine model systems are critically required tools for the investigation of unknown mechanisms of melanoma development and metastasis and for developing more efficient therapies. The Tg(Grm1)EPv melanoma mouse model is characterized by spontaneous development of pigmented cutaneous melanomas at hairless skin regions, with a short latency and 100% penetrance. Local metastasis was described in initial analyses; however, melanoma cells were not observed in distant organs. Here, we demonstrate that the established Tg(Grm1)EPv melanoma mouse model exhibits more extensive metastasis into distant organs than previously described. Disseminated cells undergo phenotypic changes, as we observed high numbers of non-pigmented Grm1-expressing melanoma cells within distant organs. As such changes during metastasis are common in human melanoma, our findings demonstrate that this mouse model represents an even more useful tool to study unknown mechanisms of metastasis in human melanoma than previously assumed.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22882420     DOI: 10.1111/j.1600-0625.2012.01560.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  12 in total

1.  Identifying mouse models for skin cancer using the Mouse Tumor Biology Database.

Authors:  Dale A Begley; Debra M Krupke; Steven B Neuhauser; Joel E Richardson; Paul N Schofield; Carol J Bult; Janan T Eppig; John P Sundberg
Journal:  Exp Dermatol       Date:  2014-10       Impact factor: 3.960

2.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

Authors:  Brook Chernet; Michael Levin
Journal:  J Clin Exp Oncol       Date:  2013

3.  BMP6-induced modulation of the tumor micro-milieu.

Authors:  David Stieglitz; Susanne Lamm; Simone Braig; Lena Feuerer; Silke Kuphal; Peter Dietrich; Stephanie Arndt; Bernd Echtenacher; Claus Hellerbrand; Sigrid Karrer; Anja-Katrin Bosserhoff
Journal:  Oncogene       Date:  2018-08-31       Impact factor: 9.867

4.  Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptor.

Authors:  Jessica L F Teh; Raj Shah; Seung-Shick Shin; Yu Wen; Janice M Mehnert; James Goydos; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2014-04-11       Impact factor: 4.693

5.  Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model.

Authors:  David G Mairhofer; Daniela Ortner; Christoph H Tripp; Sandra Schaffenrath; Viktor Fleming; Lukas Heger; Kerstin Komenda; Daniela Reider; Diana Dudziak; Suzie Chen; Jürgen C Becker; Vincent Flacher; Patrizia Stoitzner
Journal:  J Invest Dermatol       Date:  2015-06-29       Impact factor: 8.551

6.  Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.

Authors:  Michael P Marciel; Vedbar S Khadka; Youping Deng; Pascal Kilicaslan; Andrew Pham; Pietro Bertino; Katie Lee; Suzie Chen; Natalija Glibetic; FuKun W Hoffmann; Michelle L Matter; Peter R Hoffmann
Journal:  Oncotarget       Date:  2018-02-03

7.  Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model.

Authors:  Miriam Martha de Jel; Mandy Schott; Susanne Lamm; Winfried Neuhuber; Silke Kuphal; Anja-Katrin Bosserhoff
Journal:  Oncogenesis       Date:  2019-10-07       Impact factor: 7.485

8.  Enhanced responses to tumor immunization following total body irradiation are time-dependent.

Authors:  Adi Diab; Robert R Jenq; Gabrielle A Rizzuto; Adam D Cohen; Deonka W Huggins; Taha Merghoub; Manuel E Engelhorn; José A Guevara-Patiño; David Suh; Vanessa M Hubbard-Lucey; Adam A Kochman; Suzie Chen; Hong Zhong; Jedd D Wolchok; Marcel R M van den Brink; Alan N Houghton; Miguel-Angel Perales
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

9.  Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.

Authors:  Ronak Savla; Olga B Garbuzenko; Suzie Chen; Lorna Rodriguez-Rodriguez; Tamara Minko
Journal:  Pharm Res       Date:  2014-06-13       Impact factor: 4.200

10.  Growth and Metastasis of Intraocular Tumors in Aged Mice.

Authors:  Zhiqiang Han; Joseph R Brown; Jerry Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.